Proprietary Patient-Centric Soft Lozenge Technology

Patient compliance often hinges on the sensory experience of oral dosage forms, especially for vulnerable populations like children, seniors, and individuals suffering from dysphagia. Advanced soft lozenge technology directly addresses these compliance barriers by providing a soothing, comfortable oral dissolution experience that is significantly less sticky and easier to tolerate than traditional hard alternatives.

Integrating active pharmaceutical ingredients into these highly customizable matrices allows for targeted dissolution profiles ranging from 10 to 30 minutes, enhanced taste-masking, and sugar-free formulation options. Supported by a robust global manufacturing footprint across North America and Europe, Thermo Fisher Scientific delivers precise dosing control, bioavailability enhancement for poorly soluble candidates, and seamless scalability from clinical development to commercial volumes.

Discover how to elevate therapeutic adherence and broaden your product’s market appeal by exploring our comprehensive technology overview.